Archives20242023202220212020201920182017201620152014201320122011 June 06, 2017Final Results Announcement for the twelve months ended 31 December 2016 Read More May 24, 2017Notification of full year results – 1st June 2017 Read More May 18, 2017Update on Lupuzor™ Pivotal Phase III Study Read More March 21, 2017Notification of Major Interest by Legal & General Read More March 10, 2017Successful £4.1 Million Fund Raise Following the Close of the Accelerated Bookbuild Read More March 10, 2017Accelerated Bookbuild for the Issue of Equity Read More January 25, 2017Update on Lupuzor™ Pivotal Phase III Study – Full Analysis of Patient Recruitment Read More January 24, 2017Change of Adviser Read More December 22, 2016Update on Lupuzor™ Pivotal Phase III Study – Patient Recruitment Completed Read More November 16, 2016Update on Cancer Compound IPP-204106 ‘Nucant’ Read More November 09, 2016Notification of Major Interest by Legal & General Read More October 26, 2016TR1 Notification of Major Interest Read More 1…1314151617…21
March 10, 2017Successful £4.1 Million Fund Raise Following the Close of the Accelerated Bookbuild Read More
January 25, 2017Update on Lupuzor™ Pivotal Phase III Study – Full Analysis of Patient Recruitment Read More
December 22, 2016Update on Lupuzor™ Pivotal Phase III Study – Patient Recruitment Completed Read More